Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices
Information
Type
Expert Opinion
Regulated products
Medical Devices
Published
June 18, 2019
Last updated
June 18, 2019
Description
Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
Tags
Organization
Country / Region
European Union
License
Creative Commons Attribution 4.0